DNA METHYLATION AND EPIGENETIC GENE SILENCING
DNA methylation is a reversible chemical modification of the cytosine in the CpG islands of promoter sequences, catalyzed by a family of DNA methyltransferases. DNA methylation does not change the genetic information but it just alters the readability of the DNA and results in the inactivation of gene by subsequent transcript repression. CpG island are the regions in DNA that contains many adjacent cytosine and guanine nucleotides. The ''p '' in CpG refers to the phosphodiester bond between the cytosine and the guanine. These islands occur in approximately 40% of the promoters of human genes. These islands occur in approximately 40% of the promoters of human genes. DNA methylation plays a critical role in the control of cellular process including embryonic development , transcription, X- chromosome inactivation and genomic imprinting. DNA methylation occurs in the C5 positions of cytosines that precedes guanines and are called dinucleotide CpGs. The CpG dinucleotides are not found frequently throughout the human genome and present 20 % of its expected frequency. But approximately half of the human gene promoter regions have CpG rich areas of 0.5 to 2 kb in length. In which CpG 

This comment has been removed by the author.
ReplyDeleteGreat post — really made the mechanisms of epigenetic gene silencing easy to follow. The clear explanation of CpG-islands and methylation-driven transcription repression was valuable. I also appreciated the depth of context linking CpG hypermethylation to cancer risk. Thanks for sharing. Thyroid Artery Embolization
ReplyDelete